Hybrid Industry Early Morning Symposium at the ERS International Congress 2023
Tuesday, 12 September 2023
07:15 – 08:15 CEST
Breakfast will be served
Allianz MiCo
Coral 2, Hall 4
Milano Convention Centre
V.le Egnardo
20149 Milano, Italy
Also Available to Virtual Attendees via Online Simulcast
FACULTY
Doreen J. Addrizzo-Harris, MD, FCCP
Professor, Medicine
Associate Director, Clinical and Academic Affairs
Co-Director, NYU Bronchiectasis/NTM Clinical and Translational Program
NYU Grossman School of Medicine
New York, United States
Stefano Aliberti, MD
Professor, Respiratory Diseases
Humanitas University
Chief, Respiratory Unit
IRCCS Humanitas Research Hospital
Milan, Italy
Pieter C. Goeminne, MD, PhD
Staff Member, Department of Respiratory Disease
VITAZ Hospital
Saint-Nicholas, Belgium
In this symposium, experts and an experienced patient share clinical pearls for the timely diagnosis and management of non-cystic fibrosis bronchiectasis (NCFBE). Do not miss this opportunity to learn more about emerging NCFBE treatment options aimed at targeting the vicious vortex of neutrophil-mediated inflammation and lung damage.
PROGRAM AGENDA
Doreen J. Addrizzo-Harris, MD, FCCP
Doreen J. Addrizzo-Harris, MD, FCCP and Panel including Experienced Patient
Identifying Risk Factors and Employing Current Guidelines
Pieter C. Goeminne, MD, PhD and Panel including Experienced Patient
The Role of Emerging Therapies Aimed at Inhibiting NSP Activation
Stefano Aliberti, MD and Panel including Experienced Patient
All Faculty
TARGET AUDIENCE
Respiratory clinicians managing patients with non-cystic fibrosis bronchiectasis (NCFBE).
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants should be better able to:
- Identify the burden of non-cystic fibrosis bronchiectasis (NCFBE) and its exacerbations on patient QoL
- Utilize clinical practice guidelines to facilitate early NCFBE recognition and diagnosis
- Assess the potential impact of targeting neutrophil serine protease (NSP) activation on the treatment of NCFBE
PROVIDER STATEMENT
This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.
SUPPORTER STATEMENT
Supported by an educational grant from Insmed.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
FEE INFORMATION
There is no fee for this educational activity.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.